Morphological changes in eosinophils are reliable markers of the severity of an acute asthma exacerbation in children

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 68, Issue 7, 2013, Pages 911-920

  Muniz Junqueira, M I ^a   Barbosa Marques, S M ^a   Junqueira, L F ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

activated eosinophils; acute asthma exacerbation; asthma; eosinophil morphological changes

Indexed keywords

ADOLESCENT; ARTICLE; ASTHMA; BLOOD SAMPLING; CELL ADHESION; CELL DEATH; CELL GRANULE; CELL SPREADING; CELL STRUCTURE; CELL VACUOLE; CHILD; CONTROLLED STUDY; CYTOPLASM; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PSEUDOPODIUM; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

EID: 84880290541     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12176     Document Type: Article

References (33)

1. GINA, Global strategy for asthma management and prevention 2010 [2012 February 13]. Available from http//:www.ginasthma.org.
2. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721.
3. Löwhagen O,. Diagnosis of asthma-a new approach. Allergy 2012; 67: 713-717.
4. Fahy JV,. Eosinophilic and neutrophilic inflammation in asthma. Insights from clinical studies. Proc Am Thorac Soc 2009; 6: 256-259.
5. Pronk-Admiraal CJ, van Haaster FE, Bartels PC,. Clinical evaluation of changes in the morphology of eosinophils. Clin Chem Lab Med 2002; 40: 27-31.
6. Adamko DJ, Odemuyiwa SO, Vethanayagam D, Moqbel R,. The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy 2005; 60: 13-22.
7. Hogan SP,. Recent advances in eosinophil biology. Int Arch Allergy Immunol 2007; 143: S3-S14.
8. Wardlaw AJ, Brightling C, Green R, Woltmann G, Pavord I,. Eosinophils in asthma and other allergic diseases. Br Med Bull 2000; 56: 985-1003.
9. Jatakanon A, Lim S, Barnes PJ,. Changes in sputum eosinophils predict loss of asthma control. Am J Respir Crit Care Med 2000; 161: 64-72.
10. Pizzichini E, Pizzichini MM, Efthimiadis A, Dolovich J, Hargreave FE,. Measuring airway inflammation in asthma: eosinophils and eosinophilic canonic protein in induced sputum compared with peripheral blood. J Allergy Clin Immunol 1997; 99: 539-544.
11. Gogate S, Katial R,. Pediatric biomarkers in asthma: exhaled nitric oxide, sputum eosinophils and leukotriene E4. Curr Opin Allergy Clin Immunol 2008; 8: 154-157.
12. Fritscher CC, Solé D, Rosário N, Fiterman J, Pastorino AC, Pereira LFF, et al. III Consenso Brasileiro no Manejo da Asma. J. Pneumol 2002; 28; S1-S28.
13. International consensus report on diagnosis and management of asthma. National Heart, Lung, and Blood Institute. National Institute of Health, Bethesda Maryland. NIH Publication 92-3091, 1992: 1-72.
14. Muniz-Junqueira MI, Peçanha LMF, Silva-Filho VL, Cardoso MCA, Tosta CE,. Novel microtechnique for assessment of postnatal maturation of the phagocytic function of neutrophils and monocytes. Clin Diagn Lab Immunol 2003; 10: 1096-1102.
15. Gleich GJ, Adolphson CR, Leiferman KM,. The biology of the eosinophilic leukocyte. Annu Rev Med 1993; 44: 85-101.
16. Kroegel C, Virchow JC Jr, Luttmann W, Walker C, Warner JA,. Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I). Eur Respir J 1994; 7: 519-543.
17. Persson CG, Erjefält JS,. "Ultimate activation" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (Cfegs). Thorax 1997; 52: 569-574.
18. Keren DF, Hruszczyk VA,. Clinical significance and cost-effectiveness of clinical immunology testing. In:, Rose NR, de Macario EC, Folds JD, Lane HC, Nakamura RM, editors. Manual of Clinical Laboratory Immunology. Washington: American Society for Microbiology Press, 1997: 1206-1212.
19. Kita H,. Eosinophils: multifaceted biological properties and roles in health and disease. Immunol Rev 2011; 242: 161-177.
20. Erjefält JS, Persson CGA,. New aspects of degranulation and fates of airway mucosal eosinophils. Am J Respir Crit Care Med 2000; 161: 2074-2085.
21. Shamri R, Xenakis JJ, Spencer LA,. Eosinophils in innate immunity: an evolving story. Cell Tissue Res 2011; 343: 57-83.
22. Neves JS, Weller PF,. Functional extracellular eosinophil granules: novel implications in eosinophil immunobiology. Curr Opin Immunol 2009; 21: 694-699.
23. Melo RC, Weller PF, Dvorak AM,. Activated human eosinophils. Int Arch Allergy Immunol 2005; 138: 347-349.
24. Lacy P, Willetts L, Kim JD, Lo AN, Lam B, MacLean EI, et al. Agonist activation of F-actin-mediated eosinophil shape change and mediator release is dependent on Rac2. Int Arch Allergy Immunol 2011; 156: 137-147.
25. Muniz-Junqueira MI, Mota LM, Aires RB, Junqueira LF Jr,. Differing phagocytic function of monocytes and neutrophils in Chagas' cardiopathy according to the presence or absence of congestive heart failure. Rev Soc Bras Med Trop 2004; 37: 447-453.
26. Muniz-Junqueira MI, Braga Lopes C, Magalhães CA, Schleicher CC, Veiga JP,. Acute and chronic influence of hemodialysis according to the membrane used on phagocytic function of neutrophils and monocytes and pro-inflammatory cytokines production in chronic renal failure patients. Life Sci 2005; 77: 3141-3155.
27. Muniz-Junqueira MI, Mota LM, Aires RB, Junqueira LF Jr,. Digitalis inhibits and furosemide does not change the in vitro phagocytic function of neutrophils of healthy subjects. Int Immunopharmacol 2003; 3: 1439-1445.
28. Muniz-Junqueira MI, de Paula-Coelho VN,. Meglumine antimonate directly increases phagocytosis, superoxide anion and TNF-alpha production, but only via TNF-alpha it indirectly increases nitric oxide production by phagocytes of healthy individuals, in vitro. Int Immunopharmacol 2008; 8: 1633-1638.
29. Zietkowski Z, Tomasiak-Lozowska MM, Skiepko R, Zietkowska E, Bodzenta-Lukaszyk A,. Eotaxin-1 in exhaled breath condensate of stable and unstable asthma patients. Respir Res 2010; 11: 110.
30. Koshak EA, Alamoudi OS,. Do eosinophil counts correlate differently with asthma severity by symptoms versus peak flow rate? Ann Allergy Asthma Immunol 1999; 83: 567-571.
31. Bakakos P, Schleich F, Alchanatis M, Louis R,. Induced sputum in asthma: from bench to bedside. Curr Med Chem 2011; 18: 1415-1422.
32. van der Valk RJP, Baraldi E, Stern G, Frey U, de Jongste JC,. Daily exhaled nitric oxide measurements and asthma exacerbations in children. Allergy 2012; 67: 265-271.
33. Fleming L, Wilson N, Regamey N, Bush A,. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012; 67: 193-198. Tecnológico